Company Filing History:
Years Active: 2022-2024
Title: Sreekanth Rajan: Innovator in Nurr1 Modulation
Introduction
Sreekanth Rajan is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biochemistry, particularly in the area of nuclear receptor modulation. With a total of 2 patents, his work focuses on innovative methods and compounds that can influence biological processes.
Latest Patents
Sreekanth Rajan's latest patents include the development of co-crystals of NURR1-lbd in complex with a cyclopentenone prostaglandin. These co-crystals comprise the Nuclear receptor related 1 protein-ligand binding domain (Nurr1-LBD) and a cyclopentenone prostaglandin. The patents also detail methods for identifying or designing Nurr1-modulating ligands and compounds based on the described crystal structures. The applications of these ligands and compounds as Nurr1 modulators or medicaments are also highlighted.
Career Highlights
Sreekanth Rajan is affiliated with Nanyang Technological University, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic development.
Collaborations
Some of his notable coworkers include Ho Sup Yoon and Hui Ting Toh, who contribute to the collaborative research efforts at Nanyang Technological University.
Conclusion
Sreekanth Rajan's innovative work in the field of Nurr1 modulation showcases his commitment to advancing scientific knowledge and therapeutic possibilities. His contributions are paving the way for future developments in biochemistry and medicine.